A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma (Q65536130)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma |
clinical trial |
Statements
SUMMIT-1 (English)
0 references
A Randomized Phase 3 Study of Tasisulam-sodium Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle Versus Paclitaxel as Second-line Treatment in Patients With Metastatic Melanoma (English)
0 references
December 2009
0 references
March 2011
0 references
336
0 references
18 year
0 references